| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles
Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy
JA Cairns and SJ Connolly
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
Article topics:
- Pharmacology..Heart Diseases (Drug Development)
- Medicine..Atrial Fibrillation
- Medicine..Anticoagulants
- Medicine..Clinical Trials
- Medicine..Epidemiology
- Microbiology..Rheumatic Heart Disease
- Medicine..Mitral Valve Stenosis
- Medicine..Pathologic Constriction
- Medicine..Embolization
- Medicine..Heart Diseases
- Medicine..Hypertension, Therapy
- Medicine..Echocardiography
- Neuroscience..Cerebrovascular Accident
This article has been cited by other articles:
 |
|
 |
|
  Y. Miyasaka, M. E. Barnes, B. J. Gersh, S. S. Cha, K. R. Bailey, W. P. Abhayaratna, J. B. Seward, and T. S.M. Tsang Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence Circulation, July 11, 2006; 114(2): 119 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. van der Hooft, J. Heeringa, G. G. Brusselle, A. Hofman, J. C. M. Witteman, J. H. Kingma, M. C. J. M. Sturkenboom, and B. H. Ch. Stricker Corticosteroids and the risk of atrial fibrillation. Arch Intern Med, May 8, 2006; 166(9): 1016 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. van der Hooft, J. Heeringa, G. van Herpen, J. A. Kors, J. H. Kingma, and B. H. Ch. Stricker Drug-induced atrial fibrillation J. Am. Coll. Cardiol., December 7, 2004; 44(11): 2117 - 2124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Perez-Gomez, E. Alegria, J. Berjon, J. A. Iriarte, J. Zumalde, A. Salvador, L. Mataix, and NASPEAF Investigators Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: A randomized multicenter study J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1557 - 1566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Romano, D. S. Bach, F. D. Pagani, R. L. Prager, G. M. Deeb, and S. F. Bolling Atrial reduction plasty Cox maze procedure: extended indications for atrial fibrillation surgery Ann. Thorac. Surg., April 1, 2004; 77(4): 1282 - 1287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R Kasliwal, S. Mukesh, G. Manohar, N. Aggarwal, and A. Bhatia Pharmacotherapy of Atrial Fibrillation Asian Cardiovasc Thorac Ann, December 1, 2003; 11(4): 364 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Everett IV, J. R. Moorman, L.-C. Kok, J. G. Akar, and D. E. Haines Assessment of Global Atrial Fibrillation Organization to Optimize Timing of Atrial Defibrillation Circulation, June 12, 2001; 103(23): 2857 - 2861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Klein, R. D. Murray, and R. A. Grimm Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation J. Am. Coll. Cardiol., March 1, 2001; 37(3): 691 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F C Taylor, H Cohen, and S Ebrahim Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation BMJ, February 10, 2001; 322(7282): 321 - 326. [Abstract] [Full Text]
|
|
|
|
|
|
S. S. Chugh, J. L. Blackshear, W.-K. Shen, S. C. Hammill, and B. J. Gersh Epidemiology and natural history of atrial fibrillation: clinical implications J. Am. Coll. Cardiol., February 1, 2001; 37(2): 371 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Nakazawa, D.A Lythall, J Noh, N Ishikawa, K Sugino, K Ito, and S.M.C Hardman Is there a place for the late cardioversion of atrial fibrillation?. A long-term follow-up study of patients with post-thyrotoxic atrial fibrillation Eur. Heart J., February 2, 2000; 21(4): 327 - 333. [Abstract] [PDF]
|
|
|
|
 |
|
 M Gasparini, M Mantica, M Brignole, L Gianfranchi, C Menozzi, F Pizzetti, G Magenta, P Delise, A Proclemer, S Tognarin, et al. Thromboembolism after atrioventricular node ablation and pacing: long term follow up Heart, October 1, 1999; 82(4): 494 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Bosch, X. Zeng, J. B. Grammer, K. Popovic, C. Mewis, and V. Kuhlkamp Ionic mechanisms of electrical remodeling in human atrial fibrillation Cardiovasc Res, October 1, 1999; 44(1): 121 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Gullov, B. G. Koefoed, and P. Petersen Bleeding During Warfarin and Aspirin Therapy in Patients With Atrial Fibrillation: The AFASAK 2 Study Arch Intern Med, June 28, 1999; 159(12): 1322 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Farshi, D. Kistner, J. S. M. Sarma, J. A. Longmate, and B. N. Singh Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens J. Am. Coll. Cardiol., February 1, 1999; 33(2): 304 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Y. H. Lip, A. Rumley, F. G. Dunn, and G. D. O. Lowe Thrombogenesis in Mitral Regurgitation and Aortic Stenosis Angiology, December 1, 1996; 47(12): 1117 - 1125. [Abstract] [PDF]
|
|
|
|
|
|
S. J. Connolly, C. Kerr, M. Gent, and S. Yusuf Dual-Chamber Versus Ventricular Pacing: Critical Appraisal of Current Data Circulation, August 1, 1996; 94(3): 578 - 583. [Full Text]
|
|
|
|
|
|
D. G. Zarembski, P. E. Nolan Jr, M. K. Slack, and A. C. Caruso Treatment of Resistant Atrial Fibrillation: A Meta-analysis Comparing Amiodarone and Flecainide Arch Intern Med, September 25, 1995; 155(17): 1885 - 1891. [Abstract] [PDF]
|
|
|
|
|
|
L. J. Collins, D. I. Silverman, P. S. Douglas, and W. J. Manning Cardioversion of Nonrheumatic Atrial Fibrillation : Reduced Thromboembolic Complications With 4 Weeks of Precardioversion Anticoagulation Are Related to Atrial Thrombus Resolution Circulation, July 15, 1995; 92(2): 160 - 163. [Abstract] [Full Text]
|
|
|
|
|
|
H. R. Middlekauff, W. G. Stevenson, and J. A. Gornbein Antiarrhythmic Prophylaxis vs Warfarin Anticoagulation to Prevent Thromboembolic Events Among Patients With Atrial Fibrillation: A Decision Analysis Arch Intern Med, May 8, 1995; 155(9): 913 - 920. [Abstract] [PDF]
|
|
|
|
|
|
W. M. Feinberg, J. L. Blackshear, A. Laupacis, R. Kronmal, and R. G. Hart Prevalence, Age Distribution, and Gender of Patients With Atrial Fibrillation: Analysis and Implications Arch Intern Med, March 13, 1995; 155(5): 469 - 473. [Abstract] [PDF]
|
|
|
|
|
|
L. K. Gottlieb and S. Salem-Schatz Anticoagulation in Atrial Fibrillation: Does Efficacy in Clinical Trials Translate Into Effectiveness in Practice? Arch Intern Med, September 12, 1994; 154(17): 1945 - 1953. [Abstract] [PDF]
|
|
|
|
 |
|
 Warfarin or aspirin for non-rheumatic atrial fibrillation? DTB, August 1, 1994; 32(8): 57 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Daniel Should Transesophageal Echocardiography Be Used to Guide Cardioversion? N. Engl. J. Med., March 18, 1993; 328(11): 803 - 804. [Full Text]
|
|
|
|
 |
|
 S. T. Mennemeyer and J. W. Winkelman Searching for Inaccuracy in Clinical Laboratory Testing Using Medicare Data: Evidence for Prothrombin Time JAMA, February 24, 1993; 269(8): 1030 - 1033. [Abstract] [PDF]
|
|
|
|
|
|
N. A. M. Estes III Evolving Strategies for the Management of Atrial Fibrillation: The Role of Amiodarone JAMA, June 24, 1992; 267(24): 3332 - 3333. [Abstract] [PDF]
|
|
|
|
 |
|
 H. R. Middlekauff, I. Wiener, L. A. Saxon, and W. G. Stevenson Low-Dose Amiodarone for Atrial Fibrillation: Time for a Prospective Study? Ann Intern Med, June 15, 1992; 116(12_Part_1): 1017 - 1020. [Abstract] [PDF]
|
|
|
|
|
|
H. I. Bussey, R. W. Force, T. M. Bianco, and A. D. Leonard Reliance on Prothrombin Time Ratios Causes Significant Errors in Anticoagulation Therapy Arch Intern Med, February 1, 1992; 152(2): 278 - 282. [Abstract] [PDF]
|
|
|
|
 |
|
 PREVENTING STROKE IN ATRIAL FIBRILLATION: SOME ANSWERS, MORE QUESTIONS Journal Watch (General), August 23, 1991; 1991(823): 6 - 6. [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||